AC-170 0.24%

AC-170 · Aciex Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AC-170 0.24%, covering 2017-07-26 to 2017-11-09. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle [Phase 3]